Medical Education Library

A Practical Update on Sexually Transmitted Infections: Advances in Diagnosis and Treatment


 

A supplement to Ob. Gyn. News.
Supported by a restricted educational grant from 3M Pharmaceuticals.
Highlights of presentations that took place at a continuing medical education conference held April 5-6, 2003, Washington, DC.


Contents/Faculty Disclosure


To view the supplement, click the image above.

Contents/Faculty Disclosure

Introduction
Jack D. Sobel, MD
Professor, Chief
Division of Infectious Disease
Wayne State University School of Medicine
Harper Hospital
Detroit, MI
Clinical Grants: 3M Pharmaceuticals, Pfizer, and Ortho-McNeil. Discusses the investigational use of fluconazole and 17.4% topical flucytosine cream for treating Candida glabrata, and 10% hydrocortisone for treating erosive lichen planus.

Phillip G. Stubblefield, MD
Professor and Chairman, Obstetrics and Gynecology
Boston University School of Medicine
Director, Obstetrics and Gynecology
Boston Medical Center
Boston, MA
Nothing to disclose.

Jonathan M. Zenilman, MD
Professor, Infectious Diseases Division
Johns Hopkins School of Medicine
Baltimore, MD
Clinical Grants/Research: Osmetech PLC; Consultant: Merck and Company; Speaker's Bureau: GlaxoSmithKline, Pfizer, Inc.

Normal Vaginal Flora
Jeanne M. Marrazzo, MD, MPH
Assistant Professor, Department of Medicine
Division of Allergy and Infectious Diseases
University of Washington, Harborview Medical Center
Seattle, WA
Discusses the use of intravaginal Lactobacillus crispatus capsules for the treatment of bacterial vaginosis.

Diagnosis and Treatment of Routine and Resistant Trichomoniasis
Anne M. Rompalo, MD, ScM
Associate Professor, Infectious Diseases Division
Johns Hopkins School of Medicine
Baltimore, MD
Clinical Grants/Research: GlaxoSmithKline; Speaker's Bureau: GlaxoSmithKline, Pfizer, Inc.

New Findings in Routine and Recurrent Vulvovaginal Candidiasis Treatment
Jack D. Sobel, MD

Overview of Bacterial Vaginosis and Its Role in Upper Genital Tract Infection
David A. Eschenbach, MD
Professor and Director, Women's Health
Chair, Department of Obstetrics and Gynecology
University of Washington
Seattle, WA
Consultant: 3M Pharmaceuticals.

Noninfectious Vulvovaginal Symptoms as Manifestations of Systemic Diseases
Jack D. Sobel, MD


Copyright © 2003 by International Medical News Group

Recommended Reading

After Age 30, Cervical Ca Screening Intervals Extended
MDedge ObGyn
FDA Ponders Making More Drugs Nonprescription
MDedge ObGyn
Will Expanded Use of EMRs Fuel Keyboard Contamination?
MDedge ObGyn
Investigational Herpes Drug May Offer Alternative to Valacyclovir
MDedge ObGyn
Antibiotics Lead Outpatient Cutaneous Adverse Drug Events
MDedge ObGyn
Pain Medicine Rocked by Perception of Conflicts
MDedge ObGyn
Evidence Mounts for Aspirin's Anticancer Attributes
MDedge ObGyn
Getting Ready for the Insurance Exchanges
MDedge ObGyn
That's a Latte of Tanning Salons!
MDedge ObGyn
Clinical Update: Managing Women's Digestive Health
MDedge ObGyn